参考文献/References:
[1] 王江业,张倍宁,孙国良,等.温阳扶正方治疗晚期结肠癌脾肾阳虚证临床研究[J].陕西中医,2024,45(2):196-199.
[2] TAO L,SONG P,SHAO L,et al.MiR-129-2-3p inhibits colon cancer cell proliferation by down-regulating the expression of BZW1[J].Arab J Gastroenterol,2024,25(1):42-50.
[3] YUN Z Y,WU D,WANG X,et al.MiR-214-3p overexpression-triggered chondroitin polymerizing factor(CHPF)inhibition modulates the ferroptosis and metabolism in colon cancer[J].Kaohsiung J Med Sci,2024,40(3):244-254.
[4] 张文娟,王琰琰,周静祎,等.微小RNA-181c-5p和Kruppel样因子6在子宫内膜样腺癌组织中的表达及其与患者临床病理特征关系研究[J].陕西医学杂志,2024,53(4):552-555.
[5] 荆春霞,袁高亮,于蕾,等.miR-497-5p、miR-3607-3p与宫颈癌合并高危型HPV感染的相关性分析[J].中国艾滋病性病,2024,30(2):167-171.
[6] DENG Y,HUANG H,SHI J,et al.Identification of candidate genes in breast cancer induced by estrogen plus progestogens using bioinformatic analysis[J].Int J Mol Sci,2022,23(19):11892-11915.
[7] ZHANG X,YANG L,HUANG B,et al.Identification and validation of cyclin A2 and cyclin E2 as potential biomarkers in small cell lung cancer[J].Oncol Res Treat,2023,46(6):246-258.
[8] WANG Q,WU H,WU Q,et al.Berberine targets KIF20A and CCNE2 to inhibit the progression of nonsmall cell lung cancer via the PI3K/AKT pathway[J].Drug Dev Res,2023,84(5):907-921.
[9] GAO P,WANG H,YU J,et al.MiR-3607-3p suppresses non-small cell lung cancer(NSCLC)by targeting TGFBR1 and CCNE2[J].PLoS Genet,2018,14(12):e1007790.
[10] 中华人民共和国卫生部.结肠癌规范化诊疗指南(试行)[J].慢性病学杂志,2013,14(7):481-485.
[11] 万里,程如焕,邹绍静,等.结肠癌组织中HIF-1α和FoxM1的表达及其与临床病理特征和预后关系的研究[J].国际消化病杂志,2022,42(5):294-299.
[12] MONTMINY E M,ZHOU M,LONG C,et al.Impact of carcinoid and appendiceal site inclusion on early onset colon cancer incidence rate analysis in the United States[J].Clin Gastroenterol Hepatol,2023,21(11):2972-2974.
[13] 徐敏,王彦舟,张华.全身炎性反应指数联合控制营养状况评分对结肠癌患者预后的预测价值[J].陕西医学杂志,2023,52(11):1558-1562,1566.
[14] MO T W,ZHANG Z J,CHEN Y L,et al.Risk factors for metachronous peritoneal carcinomatosis after radical resection for patients with nonmetastatic pT3-4 colon cancer[J].J Surg Oncol,2022,126(4):757-771.
[15] YAN J,ZHAO Z,WANG L,et al.Construction of predictive model for prognosis of patients after radical resection of colon cancer based on nomogram[J].Am J Transl Res,2023,15(4):2783-2792.
[16] JI Y,GU J,ZHANG H,et al.Identification and validation of key miRNAs for colon cancer based on miRNA-gene integration analysis[J].Int J Gen Med,2023,16:5703-5718.
[17] 张琳,邓贵华,杨亮,等.苦木碱F通过miR-331-3p调控宫颈癌 HeLa细胞增殖及凋亡的机制研究[J].陕西中医,2022,43(1):17-22.
[18] LOU W,CHEN J,DING B,et al.XIAP,commonly targeted by tumor suppressive miR-3607-5p and miR-3607-3p,promotes proliferation and inhibits apoptosis in hepatocellular carcinoma[J].Genomics,2021,113(3):933-945.
[19] 陈一蕊,勾朝阳,李新阳.宫颈癌患者血清miR-3607-3p水平与人乳头瘤病毒感染相关性[J].中国计划生育学杂志,2022,30(2):470-473.
[20] TAO K,LIU J,LIANG J,et al.Vascular endothelial cell-derived exosomal miR-30a-5p inhibits lung adenocarcinoma malignant progression by targeting CCNE2[J].Carcinogenesis,2021,42(8):1056-1067.
[21] WANG J F,XI Z N,SU H J,et al.SP1-induced overexpression of LINC00520 facilitates non-small cell lung cancer progression through miR-577/CCNE2 pathway and predicts poor prognosis[J].Hum Cell,2021,34(3):952-964.
[22] WELSCH E,SCHUSTER E,KRAINER M,et al.Comparison of RNA marker panels for circulating tumor cells and evaluation of their prognostic relevance in breast cancer[J].Cancers(Basel),2023,15(4):1271-1288.
[23] SHEN J,HU J,WU J,et al.Molecular characterization of long-term survivors of hepatocellular carcinoma[J].Aging(Albany NY),2021,13(5):7517-7537.
[24] 王江波,梁皓,陆允平.miRNA-144-3p靶向CCNE2调控肺腺癌细胞周期并抑制其增殖[J].实用药物与临床,2023,26(6):481-487.
[25] LI H,FENG H,ZHANG T,et al.CircHAS2 activates CCNE2 to promote cell proliferation and sensitizes the response of colorectal cancer to anlotinib[J].Mol Cancer,2024,23(1):59-77.
相似文献/References:
[1]王 雄,张月飞,赵东雄,等.初诊结肠癌患者血小板相关指标与临床分期关系分析[J].陕西医学杂志,2019,(12):1676.
[2]龚 磊,吕真冰,喻 晶,等.SIRT1、Phospho-SIRT1在结肠癌组织中的表达及临床意义*[J].陕西医学杂志,2020,49(3):274.
GONG Lei,LV Zhenbing,YU Jing,et al.Expression and clinical significance of SIRT1 and Phospho-SIRT1 in colon cancer tissues[J].,2020,49(8):274.
[3]冯 婷,刘 霞,高立勇.叉头框转录因子O亚族3a对结肠癌SW620细胞的影响及机制研究[J].陕西医学杂志,2021,50(9):1068.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.007]
FENG Ting,LIU Xia,GAO Liyong.Effect and mechanism of FOXO3a on colon cancer SW620 cells[J].,2021,50(8):1068.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.007]
[4]顾 勇,杨 艳,符 翠,等.白藜芦醇对结肠癌恶性生物学行为的抑制作用研究[J].陕西医学杂志,2021,50(9):1072.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.008]
GU Yong,YANG Yan,FU Cui,et al.Inhibitory effect of resveratrol on malignant biological behavior of colon cancer[J].,2021,50(8):1072.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.008]
[5]余 亮,郭 建,周国强,等.结肠癌患者血清微小RNA-193a-5p和微小RNA-139-5p表达检测及其对预后的影响[J].陕西医学杂志,2023,52(6):745.[doi:DOI:10.3969/j.issn.1000-7377.2023.06.024]
YU Liang,GUO Jian,ZHOU Guoqiang,et al.Expression of serum miR-193a-5p and miRNA-139-5p in patients with colon cancer and their effects on prognosis[J].,2023,52(8):745.[doi:DOI:10.3969/j.issn.1000-7377.2023.06.024]
[6]徐 敏,王彦舟,张 华.全身炎性反应指数联合控制营养状况评分对结肠癌患者预后的预测价值[J].陕西医学杂志,2023,52(11):1558.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.023]
XU Min,WANG Yanzhou,ZHANG Hua.Predictive value of SIRI combined with CONUT score in prognosis of patients with colon cancer[J].,2023,52(8):1558.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.023]
[7]谭 蕊,李 论,罗 登.飞燕草素调控RhoA/ROCK信号通路对结肠癌细胞生物学行为及血管生成拟态形成的影响[J].陕西医学杂志,2024,(11):1468.[doi:DOI:10.3969/j.issn.1000-7377.2024.11.006]
TAN Rui,LI Lun,LUO Deng.Effects of delphinidin on the biological behavior and vasculogenic mimicry formation of colon cancer cells by regulating the RhoA/ROCK signaling pathway[J].,2024,(8):1468.[doi:DOI:10.3969/j.issn.1000-7377.2024.11.006]